Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment

Neuroscience

Volumn 217, Issue , 2012, Pages 6-18

  Howell, M D ^a   Gottschall, P E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

ADAMTS; Chondroitin sulfate proteoglycan; Extracellular matrix; Metalloproteinase; MMP; Neural plasticity

Indexed keywords

ADAM PROTEIN; CHONDROITIN ABC LYASE; CHONDROITIN SULFATE; LECTICAN; MATRIX METALLOPROTEINASE; PROTEOGLYCAN; UNCLASSIFIED DRUG;

CELL FUNCTION; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM; CONFORMATION; DENDRITIC SPINE; DISEASES; EXTRACELLULAR MATRIX; GLIA; HUMAN; MICROENVIRONMENT; NERVE CELL; NERVE CELL LESION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REINNERVATION; REVIEW; SCAR;

ANIMALS; BRAIN; CHONDROITIN SULFATE PROTEOGLYCANS; EXTRACELLULAR MATRIX; METALLOPROTEASES; NEURONAL PLASTICITY; NEURONS;

EID: 84862690406     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.05.034     Document Type: Review

References (155)

1. Ahmed Z., Dent R.G., Leadbeater W.E., Smith C., Berry M., Logan A. Matrix metalloproteases: degradation of the inhibitory environment of the transected optic nerve and the scar by regenerating axons. Mol Cell Neurosci 2005, 28:64-78.
2. Ajmo J.M., Eakin A.K., Hamel M.G., Gottschall P.E. Discordant localization of WFA reactivity and brevican/ADAMTS-derived fragment in rodent brain. BMC Neurosci 2008, 9:14.
3. Ajmo J.M., Bailey L.A., Howell M.D., Cortez L.K., Pennypacker K.R., Mehta H.N., Morgan D., Gordon M.N., Gottschall P.E. Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw. J Neurochem 2010, 113:784-795.
4. Apte S.S. A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol 2004, 36:981-985.
5. Arner E.C. Aggrecanase-mediated cartilage degradation. Curr Opin Pharmacol 2002, 2:322-329.
6. Asher R.A., Morgenstern D.A., Fidler P.S., Adcock K.H., Oohira A., Braistead J.E., Levine J.M., Margolis R.U., Rogers J.H., Fawcett J.W. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 2000, 20:2427-2438.
7. Aspberg A., Miura R., Bourdoulous S., Shimonaka M., Heinegard D., Schachner M., Ruoslahti E., Yamaguchi Y. The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc Natl Acad Sci U S A 1997, 94:10116-10121.
8. Barritt A.W., Davies M., Marchand F., Hartley R., Grist J., Yip P., McMahon S.B., Bradbury E.J. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci 2006, 26:10856-10867.
9. Bilousova T.V., Rusakov D.A., Ethell D.W., Ethell I.M. Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation. J Neurochem 2006, 97:44-56.
10. Bozdagi O., Nagy V., Kwei K.T., Huntley G.W. In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J Neurophysiol 2007, 98:334-344.
11. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
12. Brew K., Dinakarpandian D., Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000, 1477:267-283.
13. Bukhari N., Torres L., Robinson J.K., Tsirka S.E. Axonal regrowth after spinal cord injury via chondroitinase and the tissue plasminogen activator (tPA)/plasmin system. J Neurosci 2011, 31:14931-14943.
14. Busch S.A., Silver J. The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol 2007, 17:120-127.
15. Busch S.A., Horn K.P., Silver D.J., Silver J. Overcoming macrophage-mediated axonal dieback following CNS injury. J Neurosci 2009, 29:9967-9976.
16. Busch S.A., Hamilton J.A., Horn K.P., Cuascut F.X., Cutrone R., Lehman N., Deans R.J., Ting A.E., Mays R.W., Silver J. Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. J Neurosci 2011, 31:944-953.
17. Cafferty W.B., Yang S.H., Duffy P.J., Li S., Strittmatter S.M. Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci 2007, 27:2176-2185.
18. Canning D.R., McKeon R.J., DeWitt D.A., Perry G., Wujek J.R., Frederickson R.C., Silver J. Beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp Neurol 1993, 124:289-298.
19. Carulli D., Laabs T., Geller H.M., Fawcett J.W. Chondroitin sulfate proteoglycans in neural development and regeneration. Curr Opin Neurobiol 2005, 15:116-120.
20. Carulli D., Pizzorusso T., Kwok J.C., Putignano E., Poli A., Forostyak S., Andrews M.R., Deepa S.S., Glant T.T., Fawcett J.W. Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain 2010, 133:2331-2347.
21. Conant K., Wang Y., Szklarczyk A., Dudak A., Mattson M.P., Lim S.T. Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation. Neuroscience 2010, 166:508-521.
22. Conant K., Lonskaya I., Szklarczyk A., Krall C., Steiner J., Maguire-Zeiss K., Lim S.T. Methamphetamine-associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule-5. J Neurochem 2011, 118:521-532.
23. Condic M.L., Lemons M.L. Extracellular matrix in spinal cord regeneration: getting beyond attraction and inhibition. Neuroreport 2002, 13:A37-48.
24. Cowell S., Knauper V., Stewart M.L., D'Ortho M.P., Stanton H., Hembry R.M., Lopez-Otin C., Reynolds J.J., Murphy G. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 1998, 331(Pt. 2):453-458.
25. Davies J.E., Tang X., Denning J.W., Archibald S.J., Davies S.J. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries. Eur J Neurosci 2004, 19:1226-1242.
26. Deepa S.S., Carulli D., Galtrey C., Rhodes K., Fukuda J., Mikami T., Sugahara K., Fawcett J.W. Composition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycans. J Biol Chem 2006, 281:17789-17800.
27. Deller T., Haas C.A., Frotscher M. Reorganization of the rat fascia dentata after a unilateral entorhinal cortex lesion. Role of the extracellular matrix. Ann N Y Acad Sci 2000, 911:207-220.
28. Deller T., Bas Orth C., Vlachos A., Merten T., Del Turco D., Dehn D., Mundel P., Frotscher M. Plasticity of synaptopodin and the spine apparatus organelle in the rat fascia dentata following entorhinal cortex lesion. J Comp Neurol 2006, 499:471-484.
29. DeWitt D.A., Silver J. Regenerative failure: a potential mechanism for neuritic dystrophy in Alzheimer's disease. Exp Neurol 1996, 142:103-110.
30. DeWitt D.A., Silver J., Canning D.R., Perry G. Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp Neurol 1993, 121:149-152.
31. Dityatev A., Schachner M., Sonderegger P. The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat Rev Neurosci 2010, 11:735-746.
32. Duchossoy Y., Horvat J.C., Stettler O. MMP-related gelatinase activity is strongly induced in scar tissue of injured adult spinal cord and forms pathways for ingrowing neurites. Mol Cell Neurosci 2001, 17:945-956.
33. Esko J.D., Kimata K., Lindahl U. Proteoglycan and sulfated glycosaminoglycans. Essentials of glycobiology 2009, 229-248. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 2nd ed. A. Varki, R.D. Cummings, J.D. Esko, H.F. Hudson, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler (Eds.).
34. Faissner A., Pyka M., Geissler M., Sobik T., Frischknecht R., Gundelfinger E.D., Seidenbecher C. Contributions of astrocytes to synapse formation and maturation - potential functions of the perisynaptic extracellular matrix. Brain Res Rev 2010, 63:26-38.
35. Fawcett J. Molecular control of brain plasticity and repair. Prog Brain Res 2009, 175:501-509.
36. Filous A.R., Miller J.H., Coulson-Thomas Y.M., Horn K.P., Alilain W.J., Silver J. Immature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABC. Dev Neurobiol 2010, 70:826-841.
37. Fisher D., Xing B., Dill J., Li H., Hoang H.H., Zhao Z., Yang X.L., Bachoo R., Cannon S., Longo F.M., Sheng M., Silver J., Li S. Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J Neurosci 2011, 31:14051-14066.
38. Fosang A.J., Neame P.J., Last K., Hardingham T.E., Murphy G., Hamilton J.A. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol Chem 1992, 267:19470-19474.
39. Frischknecht R., Heine M., Perrais D., Seidenbecher C.I., Choquet D., Gundelfinger E.D. Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity. Nat Neurosci 2009, 12:897-904.
40. Fryer H.J., Kelly G.M., Molinaro L., Hockfield S. The high molecular weight Cat-301 chondroitin sulfate proteoglycan from brain is related to the large aggregating proteoglycan from cartilage, aggrecan. J Biol Chem 1992, 267:9874-9883.
41. Galko M.J., Tessier-Lavigne M. Function of an axonal chemoattractant modulated by metalloprotease activity. Science 2000, 289:1365-1367.
42. Galtrey C.M., Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 2007, 54:1-18.
43. Gao G., Westling J., Thompson V.P., Howell T.D., Gottschall P.E., Sandy J.D. Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation. J Biol Chem 2002, 277:11034-11041.
44. Gawlak M., Gorkiewicz T., Gorlewicz A., Konopacki F.A., Kaczmarek L., Wilczynski G.M. High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses. Neuroscience 2009, 158:167-176.
45. Gogolla N., Caroni P., Luthi A., Herry C. Perineuronal nets protect fear memories from erasure. Science 2009, 325:1258-1261.
46. Gonthier B., Nasarre C., Roth L., Perraut M., Thomasset N., Roussel G., Aunis D., Bagnard D. Functional interaction between matrix metalloproteinase-3 and semaphorin-3C during cortical axonal growth and guidance. Cereb Cortex 2007, 17:1712-1721.
47. Gottschall P.E., Sandy J.D., Zimmerman D.R. Substrates for metalloendopeptidases in the central nervous system. Matrix metalloproteinases in the central nervous system 2005, 87-118. Imperial College Press, London. K. Conant, P.E. Gottschall (Eds.).
48. Hagihara K., Miura R., Kosaki R., Berglund E., Ranscht B., Yamaguchi Y. Immunohistochemical evidence for the brevican-tenascin-R interaction: colocalization in perineuronal nets suggests a physiological role for the interaction in the adult rat brain. J Comp Neurol 1999, 410:256-264.
49. Hamel M.G., Mayer J., Gottschall P.E. Altered production and proteolytic processing of brevican by transforming growth factor beta in cultured astrocytes. J Neurochem 2005, 93:1533-1541.
50. Hamel M.G., Ajmo J.M., Leonardo C.C., Zuo F., Sandy J.D., Gottschall P.E. Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extension. Exp Neurol 2008, 210:428-440.
51. Hashimoto G., Aoki T., Nakamura H., Tanzawa K., Okada Y. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett 2001, 494:192-195.
52. Hayashita-Kinoh H., Kinoh H., Okada A., Komori K., Itoh Y., Chiba T., Kajita M., Yana I., Seiki M. Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth. Cell Growth Differ 2001, 12:573-580.
53. Heine W., Conant K., Griffin J.W., Hoke A. Transplanted neural stem cells promote axonal regeneration through chronically denervated peripheral nerves. Exp Neurol 2004, 189:231-240.
54. Hockfield S., Tootell R.B., Zaremba S. Molecular differences among neurons reveal an organization of human visual cortex. Proc Natl Acad Sci U S A 1990, 87:3027-3031.
55. Howell M.D., Gottschall P.E. Altered synaptic marker abundance in the hippocampal stratum oriens of Ts65Dn mice is associated with exuberant expression of versican. ASN Neuro 2012, 4:art:e00073. doi:http://dx.doi.org/10.1042/AN20110037.
56. Hu B., Kong L.L., Matthews R.T., Viapiano M.S. The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. J Biol Chem 2008, 283:24848-24859.
57. Huang W.C., Kuo W.C., Cherng J.H., Hsu S.H., Chen P.R., Huang S.H., Huang M.C., Liu J.C., Cheng H. Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem Biophys Res Commun 2006, 349:963-968.
58. Jaworski D.M., Kelly G.M., Piepmeier J.M., Hockfield S. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines. Cancer Res 1996, 56:2293-2298.
59. Jones G.C., Riley G.P. ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res Ther 2005, 7:160-169.
60. Kasai H., Fukuda M., Watanabe S., Hayashi-Takagi A., Noguchi J. Structural dynamics of dendritic spines in memory and cognition. Trends Neurosci 2010, 33:121-129.
61. Kashiwagi M., Tortorella M., Nagase H., Brew K. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem 2001, 276:12501-12504.
62. Kitanishi T., Ikegaya Y., Matsuki N., Yamada M.K. Experience-dependent, rapid structural changes in hippocampal pyramidal cell spines. Cereb Cortex 2009, 19:2572-2578.
63. Knauper V., Bailey L., Worley J.R., Soloway P., Patterson M.L., Murphy G. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13. FEBS Lett 2002, 532:127-130.
64. Knudsen E.I. Early experiences and critical periods. Fundamental neuroscience 2003, 555-573. Academic Press, San Diego. 2nd ed. L.R. Squire, F.E. Bloom, S.K. McConnell, J.L. Roberts, N.C. Spitzer, M.J. Zigmond (Eds.).
65. Koppe G., Bruckner G., Brauer K., Hartig W., Bigl V. Developmental patterns of proteoglycan-containing extracellular matrix in perineuronal nets and neuropil of the postnatal rat brain. Cell Tissue Res 1997, 288:33-41.
66. Koprivica V., Cho K.S., Park J.B., Yiu G., Atwal J., Gore B., Kim J.A., Lin E., Tessier-Lavigne M., Chen D.F., He Z. EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 2005, 310:106-110.
67. Kozorovitskiy Y., Gross C.G., Kopil C., Battaglia L., McBreen M., Stranahan A.M., Gould E. Experience induces structural and biochemical changes in the adult primate brain. Proc Natl Acad Sci U S A 2005, 102:17478-17482.
68. Kuno K., Kanada N., Nakashima E., Fujiki F., Ichimura F., Matsushima K. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 1997, 272:556-562.
69. Langnaese K., Seidenbecher C., Wex H., Seidel B., Hartung K., Appeltauer U., Garner A., Voss B., Mueller B., Garner C.C., Gundelfinger E.D. Protein components of a rat brain synaptic junctional protein preparation. Brain Res Mol Brain Res 1996, 42:118-122.
70. Lark M.W., Gordy J.T., Weidner J.R., Ayala J., Kimura J.H., Williams H.R., Mumford R.A., Flannery C.R., Carlson S.S., Iwata M., et al. Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain. J Biol Chem 1995, 270:2550-2556.
71. Lemons M.L., Sandy J.D., Anderson D.K., Howland D.R. Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury. J Neurosci 2001, 21:4772-4781.
72. Lingor P., Teusch N., Schwarz K., Mueller R., Mack H., Bahr M., Mueller B.K. Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo. J Neurochem 2007, 103:181-189.
73. Maeda N. Structural variation of chondroitin sulfate and its roles in the central nervous system. Cent Nerv Syst Agents Med Chem 2010, 10:22-31.
74. Maeda N., Fukazawa N., Ishii M. Chondroitin sulfate proteoglycans in neural development and plasticity. Front Biosci 2010, 15:626-644.
75. Margolis R.K., Margolis R.U., Preti C., Lai D. Distribution and metabolism of glycoproteins and glycosaminoglycans in subcellular fractions of brain. Biochemistry 1975, 14:4797-4804.
76. Massey J.M., Hubscher C.H., Wagoner M.R., Decker J.A., Amps J., Silver J., Onifer S.M. Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. J Neurosci 2006, 26:4406-4414.
77. Matsui F., Nishizuka M., Yasuda Y., Aono S., Watanabe E., Oohira A. Occurrence of a N-terminal proteolytic fragment of neurocan, not a C-terminal half, in a perineuronal net in the adult rat cerebrum. Brain Res 1998, 790:45-51.
78. Matthews R.T., Gary S.C., Zerillo C., Pratta M., Solomon K., Arner E.C., Hockfield S. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member. J Biol Chem 2000, 275:22695-22703.
79. Mayer J., Hamel M.G., Gottschall P.E. Evidence for proteolytic cleavage of brevican by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortex. BMC Neurosci 2005, 6:52.
80. McKeon R.J., Hoke A., Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol 1995, 136:32-43.
81. Meighan S.E., Meighan P.C., Choudhury P., Davis C.J., Olson M.L., Zornes P.A., Wright J.W., Harding J.W. Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. J Neurochem 2006, 96:1227-1241.
82. Michaluk P., Wawrzyniak M., Alot P., Szczot M., Wyrembek P., Mercik K., Medvedev N., Wilczek E., De Roo M., Zuschratter W., Muller D., Wilczynski G.M., Mozrzymas J.W., Stewart M.G., Kaczmarek L., Wlodarczyk J. Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology. J Cell Sci 2012, 124:3369-3380.
83. Milev P., Maurel P., Chiba A., Mevissen M., Popp S., Yamaguchi Y., Margolis R.K., Margolis R.U. Differential regulation of expression of hyaluronan-binding proteoglycans in brain: aggreacan, versican neurocan and brevican. Biochem Biophys Res Comm 1998, 247:207-2121.
84. Miura R., Aspberg A., Ethell I.M., Hagihara K., Schnaar R.L., Ruoslahti E., Yamaguchi Y. The proteoglycan lectin domain binds sulfated cell surface glycolipids and promotes cell adhesion. J Biol Chem 1999, 274:11431-11438.
85. Monnier P.P., Sierra A., Schwab J.M., Henke-Fahle S., Mueller B.K. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol Cell Neurosci 2003, 22:319-330.
86. Mora F., Segovia G., del Arco A. Aging, plasticity and environmental enrichment: structural changes and neurotransmitter dynamics in several areas of the brain. Brain Res Rev 2007, 55:78-88.
87. Morawski M., Bruckner G., Jager C., Seeger G., Arendt T. Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease. Neuroscience 2010, 169:1347-1363.
88. Morawski M., Hartlage-Rubsamen M., Jager C., Waniek A., Schilling S., Schwab C., McGeer P.L., Arendt T., Demuth H.U., Rossner S. Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease. Acta Neuropathol 2010, 120:195-207.
89. Mort J.S., Roughley P.J. Production of antibodies against degradative neoepitopes in aggrecan. Methods Mol Med 2004, 100:237-250.
90. Muir D. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp Cell Res 1994, 210:243-252.
91. Nagase H., Kashiwagi M. Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 2003, 5:94-103.
92. Nagase H., Ogata Y., Suzuki K., Enghild J.J., Salvesen G. Substrate specificities and activation mechanisms of matrix metalloproteinases. Biochem Soc Trans 1991, 19:715-718.
93. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., Costa R.M., Silva A.J., Kaczmarek L., Huntley G.W. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 2006, 26:1923-1934.
94. Noble L.J., Donovan F., Igarashi T., Goussev S., Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 2002, 22:7526-7535.
95. Nolin W.B., Emmetsberger J., Bukhari N., Zhang Y., Levine J.M., Tsirka S.E. TPA-mediated generation of plasmin is catalyzed by the proteoglycan NG2. Glia 2008, 56:177-189.
96. Nordstrom L.A., Lochner J., Yeung W., Ciment G. The metalloproteinase stromelysin-1 (transin) mediates PC12 cell growth cone invasiveness through basal laminae. Mol Cell Neurosci 1995, 6:56-68.
97. Olin A.I., Morgelin M., Sasaki T., Timpl R., Heinegard D., Aspberg A. The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem 2001, 276:1253-1261.
98. Oohira A., Matsui F., Katoh-Semba R. Inhibitory effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12D cells. J Neurosci 1991, 11:822-827.
99. Parks W.C., Wilson C.L., Lopez-Boado Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004, 4:617-629.
100. Pastrana E., Moreno-Flores M.T., Gurzov E.N., Avila J., Wandosell F., Diaz-Nido J. Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2. J Neurosci 2006, 26:5347-5359.
101. Pauly T., Ratliff M., Pietrowski E., Neugebauer R., Schlicksupp A., Kirsch J., Kuhse J. Activity-dependent shedding of the NMDA receptor glycine binding site by matrix metalloproteinase 3: a PUTATIVE mechanism of postsynaptic plasticity. PLoS One 2008, 3:e2681.
102. Perides G., Asher R.A., Lark M.W., Lane W.S., Robinson R.A., Bignami A. Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican?. Biochem J 1995, 312(Pt. 2):377-384.
103. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251.
104. Pizzorusso T., Medini P., Landi S., Baldini S., Berardi N., Maffei L. Structural and functional recovery from early monocular deprivation in adult rats. Proc Natl Acad Sci U S A 2006, 103:8517-8522.
105. Porter S., Clark I.M., Kevorkian L., Edwards D.R. The ADAMTS metalloproteinases. Biochem J 2005, 386:15-27.
106. Prange C.K., Pennacchio L.A., Lieuallen K., Fan W., Lennon G.G. Characterization of the human neurocan gene, CSPG3. Gene 1998, 221:199-205.
107. Reeves T.M., Prins M.L., Zhu J., Povlishock J.T., Phillips L.L. Matrix metalloproteinase inhibition alters functional and structural correlates of deafferentation-induced sprouting in the dentate gyrus. J Neurosci 2003, 23:10182-10189.
108. Sandy J.D., Flannery C.R., Plaas A.H. Structural studies on proteoglycan catabolism in rabbit articular cartilage explant cultures. Biochim Biophys Acta 1987, 931:255-261.
109. Sandy J.D., Flannery C.R., Neame P.J., Lohmander L.S. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 1992, 89:1512-1516.
110. Saygili E., Schauerte P., Pekassa M., Rackauskas G., Schwinger R.H., Weis J., Weber C., Marx N., Rana O.R. Sympathetic neurons express and secrete MMP-2 and MT1-MMP to control nerve sprouting via pro-NGF conversion. Cell Mol Neurobiol 2011, 31:17-25.
111. Schauwecker P.E., McNeill T.H. Dendritic remodeling of dentate granule cells following a combined entorhinal cortex/fimbria fornix lesion. Exp Neurol 1996, 141:145-153.
112. Schmalfeldt M., Bandtlow C.E., Dours-Zimmermann M.T., Winterhalter K.H., Zimmermann D.R. Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 2000, 113(Pt. 5):807-816.
113. Schmandke A., Strittmatter S.M. ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases. Neuroscientist 2007, 13:454-469.
114. Schwartz N.B., Domowicz M. Proteoglycans in brain development. Glycoconj J 2004, 21:329-341.
115. Shen Y., Tenney A.P., Busch S.A., Horn K.P., Cuascut F.X., Liu K., He Z., Silver J., Flanagan J.G. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009, 326:592-596.
116. Shubayev V.I., Myers R.R. Matrix metalloproteinase-9 promotes nerve growth factor-induced neurite elongation but not new sprout formation in vitro. J Neurosci Res 2004, 77:229-239.
117. Sivasankaran R., Pei J., Wang K.C., Zhang Y.P., Shields C.B., Xu X.M., He Z. PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration. Nat Neurosci 2004, 7:261-268.
118. Snow D.M., Lemmon V., Carrino D.A., Caplan A.I., Silver J. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp Neurol 1990, 109:111-130.
119. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001, 17:463-516.
120. Sykova E., Nicholson C. Diffusion in brain extracellular space. Physiol Rev 2008, 88:1277-1340.
121. Szklarczyk A., Lapinska J., Rylski M., McKay R.D., Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 2002, 22:920-930.
122. Szklarczyk A., Conant K., Owens D.F., Ravin R., McKay R.D., Gerfen C. Matrix metalloproteinase-7 modulates synaptic vesicle recycling and induces atrophy of neuronal synapses. Neuroscience 2007, 149:87-98.
123. Tan C.L., Kwok J.C., Patani R., Ffrench-Constant C., Chandran S., Fawcett J.W. Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. J Neurosci 2011, 31:6289-6295.
124. Tanaka Y., Mizoguchi K. Influence of aging on chondroitin sulfate proteoglycan expression and neural stem/progenitor cells in rat brain and improving effects of a herbal medicine, yokukansan. Neuroscience 2009, 164:1224-1234.
125. Tang B.L., Hong W. ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. FEBS Lett 1999, 445:223-225.
126. Thon N., Haas C.A., Rauch U., Merten T., Fassler R., Frotscher M., Deller T. The chondroitin sulphate proteoglycan brevican is upregulated by astrocytes after entorhinal cortex lesions in adult rats. Eur J Neurosci 2000, 12:2547-2558.
127. Tortorella M., Pratta M., Liu R.Q., Abbaszade I., Ross H., Burn T., Arner E. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J Biol Chem 2000, 275:25791-25797.
128. Tortorella M.D., Malfait F., Barve R.A., Shieh H.S., Malfait A.M. A review of the ADAMTS family, pharmaceutical targets of the future. Curr Pharm Des 2009, 15:2359-2374.
129. Tortorella M.D., Arner E.C., Hills R., Gormley J., Fok K., Pegg L., Munie G., Malfait A.M. ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms. Arch Biochem Biophys 2005, 444:34-44.
130. Tortorella M.D., et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999, 284:1664-1666.
131. Tsirka S.E., Rogove A.D., Bugge T.H., Degen J.L., Strickland S. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 1997, 17:543-552.
132. Viapiano M.S., Matthews R.T. From barriers to bridges: chondroitin sulfate proteoglycans in neuropathology. Trends Mol Med 2006, 12:488-496.
133. Viapiano M.S., Hockfield S., Matthews R.T. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion. J Neurooncol 2008, 88:261-272.
134. Viapiano M.S., Bi W.L., Piepmeier J., Hockfield S., Matthews R.T. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas. Cancer Res 2005, 65:6726-6733.
135. Wang D., Ichiyama R.M., Zhao R., Andrews M.R., Fawcett J.W. Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury. J Neurosci 2011, 31:9332-9344.
136. Wang P., Tortorella M., England K., Malfait A.M., Thomas G., Arner E.C., Pei D. Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network. J Biol Chem 2004, 279:15434-15440.
137. Wang X.B., Bozdagi O., Nikitczuk J.S., Zhai Z.W., Zhou Q., Huntley G.W. Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately. Proc Natl Acad Sci U S A 2008, 105:19520-19525.
138. Webber C.A., Hocking J.C., Yong V.W., Stange C.L., McFarlane S. Metalloproteases and guidance of retinal axons in the developing visual system. J Neurosci 2002, 22:8091-8100.
139. Westling J., Gottschall P.E., Thompson V.P., Cockburn A., Perides G., Zimmermann D.R., Sandy J.D. ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein. Biochem J 2004, 377:787-795.
140. Wojtowicz T., Mozrzymas J.W. Late phase of long-term potentiation in the mossy fiber-CA3 hippocampal pathway is critically dependent on metalloproteinases activity. Hippocampus 2010, 20:917-921.
141. Wu Y.P., Siao C.J., Lu W., Sung T.C., Frohman M.A., Milev P., Bugge T.H., Degen J.L., Levine J.M., Margolis R.U., Tsirka S.E. The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate. J Cell Biol 2000, 148:1295-1304.
142. Xiang Y.Y., Dong H., Wan Y., Li J., Yee A., Yang B.B., Lu W.Y. Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor. J Biol Chem 2006, 281:19358-19368.
143. Yamada H., Watanabe K., Shimonaka M., Yamasaki M., Yamaguchi Y. CDNA cloning and the identification of an aggrecanase-like cleavage site in rat brevican. Biochem Biophys Res Commun 1995, 216:957-963.
144. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 2000, 57:276-289.
145. Yang G., Pan F., Gan W.B. Stably maintained dendritic spines are associated with lifelong memories. Nature 2009, 462:920-924.
146. Yang Y., Wang X.B., Frerking M., Zhou Q. Spine expansion and stabilization associated with long-term potentiation. J Neurosci 2008, 28:5740-5751.
147. Yong V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 2005, 6:931-944.
148. Yong V.W., Power C., Forsyth P., Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001, 2:502-511.
149. Yuan W., Matthews R.T., Sandy J.D., Gottschall P.E. Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats. Neuroscience 2002, 114:1091-1101.
150. Zhang H., Trivedi A., Lee J.U., Lohela M., Lee S.M., Fandel T.M., Werb Z., Noble-Haeusslein L.J. Matrix metalloproteinase-9 and stromal cell-derived factor-1 act synergistically to support migration of blood-borne monocytes into the injured spinal cord. J Neurosci 2011, 31:15894-15903.
151. Zhang J.W., Deb S., Gottschall P.E. Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. Eur J Neurosci 1998, 10:3358-3368.
152. Zhang Y., Klassen H.J., Tucker B.A., Perez M.T., Young M.J. CNS progenitor cells promote a permissive environment for neurite outgrowth via a matrix metalloproteinase-2-dependent mechanism. J Neurosci 2007, 27:4499-4506.
153. Zimmermann D.R., Dours-Zimmermann M.T. Extracellular matrix of the central nervous system: from neglect to challenge. Histochem Cell Biol 2008, 130:635-653.
154. Zuo J., Ferguson T.A., Hernandez Y.J., Stetler-Stevenson W.G., Muir D. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J Neurosci 1998, 18:5203-5211.
155. Zuo J., Neubauer D., Dyess K., Ferguson T.A., Muir D. Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue. Exp Neurol 1998, 154:654-662.